Related Experiment Video

Updated: Jun 13, 2026

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
05:39

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease

Published on: June 13, 2025

Earliest functional declines in Huntington disease

Leigh J Beglinger1, Justin J F O'Rourke, Chiachi Wang

  • 1Department of Psychiatry, The University of Iowa, Iowa City, IA, USA.

Psychiatry Research
|May 18, 2010
PubMed

Insights

The Unified Huntington's Disease Rating Scale (UHDRS) identified early functional declines in individuals who later developed Huntington's disease (HD). Occupational, financial, and driving abilities were commonly affected before diagnosis.

Area of Science:

  • Neurology
  • Clinical Assessment
  • Neurodegenerative Diseases

Background:

  • Huntington's disease (HD) is a progressive neurodegenerative disorder.
  • Early functional assessment is crucial for monitoring disease progression and planning interventions.
  • The Unified Huntington's Disease Rating Scale (UHDRS) is the gold standard for functional assessment in HD.

Purpose of the Study:

  • To evaluate the UHDRS's ability to detect early functional decline in pre-manifest HD.
  • To identify specific skill domains that weaken first in the course of HD.
  • To determine clinical correlates associated with early functional deterioration.

Main Methods:

  • Analysis of 265 participants from Huntington Study Group clinics who were at-risk for HD but not diagnosed at baseline.
  • Utilized UHDRS Total Functional Capacity (TFC) and Functional Assessment Scale (FAS) scores.
  • Longitudinal assessment of participants who later phenoconverted to manifest HD.

Main Results:

  • Occupational decline was the most frequent early functional loss (65.1% TFC, 55.6% FAS).
  • Inability to manage finances independently (49.2% TFC, 35.1% FAS) and drive safely (33.5% FAS) were also common.
  • Motor, cognitive, and depressive symptoms significantly predicted functional decline.

Conclusions:

  • The UHDRS effectively captures early functional losses in individuals with HD prior to formal diagnosis.
  • Work performance, financial management, and driving safety are key areas for expanded assessment and clinical monitoring.
  • Addressing these functional domains is vital for treatment planning in early-stage HD.

More Related Videos

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice08:27

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice

Published on: March 11, 2020

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...